Insights On Downstream Manufacturing

  1. Efficient mAb Development With A Flexible Purification Toolkit 6/4/2026

    Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.

  2. India's Only GLP-Certified Viral Testing Facility 6/3/2026

    Get an overview of a GLP-certified viral testing facility that delivers comprehensive safety solutions, collaborative research support, and viral clearance data for biologics processes.

  3. How Solid-State Science Solves Your Toughest API Challenges 6/3/2026

    Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.

  4. Process Development And Intensification For UF/DF Of Viral Vectors 6/3/2026

    Optimizing TFF in viral vector workflows can reduce processing time while improving yield. Comparing TMP and permeate control strategies highlights key trade-offs to guide your purification decisions.

  5. Visual Inspection 5/27/2026

    Automated optical inspection enhances injectable quality by improving detection accuracy, ensuring consistency, and enabling high-speed defect and container integrity checks.

  6. Evaluating Antibody Fragment Purification Using VH3 Resin 5/22/2026

    Explore how VH-domain targeting enables efficient purification of VH3 antibody fragments and bispecific formats, with strong recoveries and flexible wash conditions that support improved purity.

  7. Mild pH Protein A Purification Step With A Mild Elution Resin 5/22/2026

    As antibody formats diversify, low-pH protein A elution can drive aggregation and yield loss. Learn how milder elution conditions during capture can help protect sensitive molecules and ease challenges.

  8. mAb Aggregate Control On-Demand Webinar 5/22/2026

    Aggregation can undermine yield and quality in downstream mAb processing. Learn practical capture, polishing, and TFF strategies to prevent and reduce aggregates, with a focus on chromatography.

  9. Keeping mAb Aggregation Low During The Final UF/DF Step 5/22/2026

    mAb aggregation can arise from molecular properties, process conditions, and equipment‑driven stress. Learn where aggregation risk increases across downstream processing and formulation.

  10. Controlling mAb Aggregates In Chromatography Process Development 5/22/2026

    Antibody aggregation remains a critical downstream challenge, particularly for complex modalities. Explore why aggregates form, why they matter, and how chromatographic strategies can help reduce risk.